Unipolar Depression: Clinical Trials

12 trials for Unipolar Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 1 terminated. 12 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 11, Terminated 1
Phase 23Completed 2, Terminated 1

Follow Unipolar Depression: new trials by email Literature Review of Unipolar Depression trials Research Report on Unipolar Depression

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine As an Adjunctive Therapy for Major Depression (2)
Ketamine, Midazolam - Major Depressive Episode, Unipolar Depression
Phase 3CompletedUniversity of Dublin, Trinity College632021-09-132025-02-13
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
electroconvulsive therapy (ECT), Ketamine - Treatment Resistant Depression, Electroconvulsive Therapy
Phase 2 / Phase 3CompletedBo Hu4032017-04-072023-09-28
Investigating tDCS as a Treatment for Unipolar and Bipolar Depression
Sham tDCS device, Soterix tDCS device - Unipolar Depression, Bipolar Depression
Phase 2 / Phase 3CompletedThe University of New South Wales1202012-06-012015-12-02
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
IPT-A - Unipolar Depression, Dysthymia
Phase 3CompletedNew York State Psychiatric Institute102011-09-012014-09-04
EScitalopram PIndolol ONset of Action
escitalopram, pindolol, escitalopram - Unipolar Depression
Phase 2 / Phase 3TerminatedMarkus KOSEL182010-10-012015-05-27
Berlin Magnetic Seizure Therapy Depression Trial 01
magnetic seizure therapy - Unipolar Depression, Bipolar Depression
Phase 3CompletedCharite University, Berlin, Germany322009-06-012018-07-13
Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression
active venlafaxine and active rTMS-repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed, active rTMS -repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and sham venlafaxine, sham rTMS- repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and active venlafaxine - Unipolar Depression
Phase 3CompletedClub rTMS et Psychiatrie1702008-05-012013-07-19
The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression
Quetiapine XR - Unipolar Depression
Phase 3CompletedUniversity of British Columbia642007-09-012010-11-16
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
Wellbutrin, Placebo - Depression, Major Depressive Disorder
Phase 3CompletedMclean Hospital322005-08-012014-08-06
Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
Rispridone (drug) and Bupropion ER (drug) - Unipolar Depression
Phase 3CompletedVanderbilt University302004-07-012015-06-02
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
triiodothyronine, sertraline - Major Depression, Bipolar Disorder
Phase 3CompletedHadassah Medical Organization2202002-10-012007-01-04
Amitriptyline and Paroxetine Treatment of Major Depression
amitriptyline, paroxetine - Unipolar Depression
Phase 3CompletedCentral Institute of Mental Health, Mannheim1271997-10-012024-01-31

Narrower conditions

Depressive Disorder (12)  ·  Depression (5)  ·  Depressive Disorder, Major (5)  ·  Bipolar Disorder (4)  ·  Depressive Disorder, Treatment-Resistant (2)  ·  Dysthymic Disorder (1)  ·  Mental Disorders (1)

Broader conditions

Mood Disorders (12)  ·  Mental Disorders (11)  ·  Behavior (5)  ·  Behavioral Symptoms (5)  ·  Bipolar and Related Disorders (4)

Interventions

Ketamine (2)  ·  Amitriptyline (1)  ·  Bupropion (1)  ·  Dexetimide (1)  ·  Electroconvulsive Therapy (1)  ·  Escitalopram (1)  ·  Midazolam (1)  ·  Paroxetine (1)  ·  Pharmaceutical Preparations (1)  ·  Pindolol (1)  ·  Sertraline (1)  ·  Triiodothyronine (1)  ·  Venlafaxine Hydrochloride (1)

Sponsors

Bo Hu (1)  ·  Central Institute of Mental Health, Mannheim (1)  ·  Charite University, Berlin, Germany (1)  ·  Club rTMS et Psychiatrie (1)  ·  Hadassah Medical Organization (1)  ·  Markus KOSEL (1)  ·  Mclean Hospital (1)  ·  New York State Psychiatric Institute (1)  ·  The University of New South Wales (1)  ·  University of British Columbia (1)  ·  University of Dublin, Trinity College (1)  ·  Vanderbilt University (1)

Countries

United States (6)  ·  Germany (2)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Ireland (1)  ·  Israel (1)  ·  Monaco (1)  ·  Switzerland (1)

Top investigators

Allan Young, MD (1)  ·  Amit Anand, MD (1)  ·  Bernard Lerer, MD (1)  ·  Beth L Murphy, MD, PhD (1)  ·  Declan M McLoughlin, PhD (1)  ·  Laura Mufson, PhD (1)  ·  Markus Kosel, MD-PhD (1)  ·  Michael Deuschle, MD (1)  ·  Richard C Shelton, MD (1)

Results publications

PMID 17548749, PMID 20952454, PMID 23277262, PMID 25192980, PMID 29111077, PMID 30172724, PMID 30572160, PMID 37224232, PMID 37361338, PMID 37974160, PMID 40900112, PMID 41123905

NIH funding

2019 (1)